Psa
Prostate-specific antigen, is a common marker used to detect prostate cancer, although it is known to be a poor prognostic marker[@duijvesz2015a]. The incidence of prostate cancer increased dramatically when PSA testing was introduced into the market in the nineties[@ramirez-garrastacho2021].
Another possibility would be to look at CD9 and CD63 in extracellular vesicles, for example Extracellular vesicles as markers for prostate cancer.
Backlinks
These are the other notes that link to this one.
Comment
Share your thoughts on this note. Comments are not public, they are
messages sent directly to my inbox.